The Bayer group said that it has gained control of 88% of Berlin-based contrast media firm Schering's approximately 191 million issued and outstanding shares.
The milestone represents the last remaining condition of the takeover bid by the Leverkusen, Germany-based Bayer, which was required to attain a three-quarters majority of outstanding Schering shares.
Remaining Schering stockholders have the opportunity to accept Bayer's offer of 89 euros ($112 U.S.) per share during an additional acceptance period, which runs from June 23 until July 6 this year. The firm said it continues to pursue its goal of wholly acquiring Schering.
Both the European Union Commission and U.S. antitrust authorities have given approval to the deal, Bayer said.
By AuntMinnie.com staff writers
June 21, 2006
Related Reading
Schering board endorses Bayer offer, April 19, 2006
Schering supports Bayer offer, Merck withdraws, March 24, 2006
Bayer cuts ties to Agfa, June 10, 2002
Copyright © 2006 AuntMinnie.com
![Axial images from unenhanced calcium score cardiac CT (left) and curved planar reformation images from CT angiography (right) show that higher long-term exposure to air pollution is associated with greater coronary artery calcium and more obstructive coronary artery disease (CAD). Top row: Images in a 68-year-old male patient with higher 10-year mean ambient air pollution exposure (7.9 μg/m3 for particulate matter measuring ≤2.5 μm in diameter [PM2.5] and 17.4 parts per billion [ppb] for NO2) with extensive CAD (coronary artery calcium score [CACS] >1,000 and obstructive CAD [≥70% diameter stenosis]). Bottom row: Images in a 57-year-old female patient with lower 10-year mean ambient air pollution exposure (6.3 μg/m3 for PM2.5 and 4.6 ppb for NO2) with no CAD (CACS = 0 and no obstructive stenosis).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/hanneman.r6SMLzkezo.png?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
